| Biotechnology Industry | Healthcare Sector | Mr. John Li CEO | SSE Exchange | CNE100004C37 ISIN |
| CN Country | 550 Employees | 29 May 2026 Last Dividend | - Last Split | - IPO Date |
HOB Biotech Group Corp., Ltd. is a prominent in vitro diagnostic company with a global presence, headquartered in Suzhou, China. Since its inception in 2009, the company has been dedicated to enhancing the care of patients suffering from allergies and autoimmune diseases. Through its innovative diagnostic tools, HOB Biotech Group has established itself as a crucial partner to laboratories and hospitals around the world, aiming to improve patient outcomes with advanced and reliable testing solutions.